Article

Expandable glide occludes pupil

A novel expanding lens glide holds promise to provide a useful addition to the cataract surgeon's armamentarium of techniques for managing cases involving a posterior capsule tear.

Boston-A novel expanding lens glide holds promise to provide a useful addition to the cataract surgeon's armamentarium of techniques for managing cases involving a posterior capsule tear, said Anita Nevyas-Wallace, MD, at the annual meeting of the American Society of Cataract and Refractive Surgery.

The device is being developed by Varitronics Inc. and still is in the prototype stage.

"The development of a capsular tear during phacoemulsification surgery presents a challenge because, while cataract surgery incisions have gotten smaller, posterior capsular tears are as large as ever," Dr. Nevyas-Wallace said.

How it works

The expanding glide is constructed of the same thin polyethylene material as a standard Sheets lens glide, but has a curved three-leaf configuration. The three leaves are held together by a tiny rivet that allows them to be swiveled easily, opening like a fan. When the handle tabs are brought together in the front, the glide is in the contracted position. To expand it, the surgeon simply brings the handle tabs together in the back.

The procedure for using the glide in the setting of a posterior capsular tear with retained nuclear fragments would be first to elevate the fragments into the anterior chamber by injecting viscoelastic. Next, the glide is inserted through the phaco incision, and once it is maneuvered under the nuclear fragments, the back handle tabs are pushed together so that the leaves separate and the glide expands to be a much wider spatula, providing greater protection against the pieces of nucleus falling posteriorly through the capsular opening.

Once removal of the nuclear fragments is accomplished, either through another incision or through an enlarged main incision, the glide elements are contracted and the device is removed.

FYI

Anita Nevyas-Wallace, MDE-mail: anevyaswallace@comcast.net

Dr. Nevyas-Wallace is a shareholder in Varitronics Inc.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.